Effect of Aprotinin on Transfusion Requirements and Blood Loss in Patients Undergoing Elective Primary Total Hip Replacement

Clinical trial NCT00668031 · COMPLETED

Trial details

NCT number: NCT00668031
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Blood Loss, Surgical

Start date: 2005-02-01
Primary completion: 2006-01-01
Enrollment: 359

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.